StonvexLoading…
StonvexStonvexStonvexCore line items from AIG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $7.36B | $6.65B | $26.77B | $20.23B | $13.87B |
Operating Income | Not available | $987.00M | $3.88B | $3.22B | $2.50B |
Net Income | Not available | $763.00M | $3.10B | $2.36B | $1.84B |
EPS (Diluted) | $1.95 | $1.41 | $5.43 | $4.08 | $3.13 |
Total Assets | Not available | $161.54B | $161.25B | $163.41B | $165.97B |
Total Liabilities | Not available | $121.11B | $120.09B | $122.30B | $124.44B |
Cash & Equivalents | Not available | $1.53B | $1.34B | $1.59B | $1.84B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 532.90M | 538.20M | 544.50M | 559.80M |